Time-Restricted Eating Helps to Improve Diabetes Outcomes
By Lori Solomon HealthDay Reporter
FRIDAY, Sept. 13, 2024 -- Time-restricted eating (TRE) may improve diabetes outcomes, independent of energy intake, according to a study presented at the annual meeting of the European Association for the Study of Diabetes, held from Sept. 9 to 13 in Madrid.
K.A. Bowden Davies, from Manchester Metropolitan University in the United Kingdom, and colleagues examined the effects of TRE in a eucaloric manner, comparing early (ETRE; 8:00-16:00 hours) versus late (LTRE; 12:00-20:00 hours) conditions on habitual (free)-living glycemic control in 15 overweight sedentary adults. In the crossover study, each phase lasted three days.
The researchers found that compared with habitual eating (>14 hours/day), TRE (eight hours/day) significantly increased time spent in euglycemia by 3.3 percent (P < 0.001) and reduced mean absolute glucose by 0.6 mmol/L (P = 0.003), coefficient of variation by 2.6 percent (P < 0.001), and mean amplitude of glucose excursions by 0.4 mmol/L (P = 0.020). There was no significant effect for ETRE versus LTRE (P > 0.05). Habitual calorie intake and macronutrient composition were similar to TRE (P > 0.05).
“Our findings, which can be attributed to the 16-hour fasting window rather than the time of eating or changes in energy intake, highlight the benefit of TRE in only three days,” the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-14 06:00
Read more
- Weed Use During Pregnancy May Harm Kids' Behavior, Thinking Skills
- Have an Implanted Defibrillator? Triple-Digit Heatwaves Could Pose Danger
- Risk for Suicidal Ideation, Attempts Down With GLP1-RA Treatment in Teens With Obesity
- Online Yoga Classes Can Ease Lower Back Pain
- Risk Factors Found for Neurogenic Bladder After Rectal Cancer Surgery
- Complete Vaccination Coverage Down in Kindergarteners for 2023-24 School Year
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions